Cold And Flu

Cold And Flu Manufacturers

• Liddell Laboratories, Inc.
  

  ×

  Cold And Flu | Liddell Laboratories, Inc.

  

  ---

  Adults and children over 12: Spray twice under the tongue three times per day. For severe symptoms, dosage may be taken up to six times the first day.

  Children 12 and under: Consult a doctor prior to use.

  Close
  No Recall

  More Info
• Hyvee Inc
  

  ×

  Cold And Flu | Hyvee Inc

  

  ---

  • do not take more than directed (see Overdose warning) • do not take more than 10 caplets in any 24-hour period • adults and children 12 years of age and older: take 2 caplets every 4 hours • children under 12 years of age: do not use

  Close
  No Recall

  More Info
• Walgreen Company
  

  ×

  Cold And Flu | H E B

  

  ---

  • take only as directed – see Overdose warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  Close
  No Recall

  More Info
• Rite Aid
  

  ×

  Cold And Flu | Pd-rx Pharmaceuticals, Inc.

  

  ---

  2.1 Dosage in Adult Patients with Normal Renal Function

  
  The usual dose of levofloxacin tablets is 250 mg, 500 mg, or 750 mg administered orally every 24 hours, as indicated by infection and described in Table 1.
  
  These recommendations apply to patients with creatinine clearance ≥ 50 mL/min. For patients with creatinine clearance <50 mL/min, adjustments to the dosing regimen are required [see Dosage and Administration (2.3)].
  

  Table 1: Dosage in Adult Patients with Normal Renal Function (creatinine clearance ≥ 50 mL/min) Type of Infection1 Dosed Every 24 hours Duration (days)2 1 Due to the designated pathogens [see Indications and Usage (1)].
  2 Sequential therapy (intravenous to oral) may be instituted at the discretion of the physician.
  3 Due to methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae (including multi-drug-resistant isolates [MDRSP]), Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydophila pneumoniae, Legionella pneumophila, or Mycoplasma pneumoniae [see Indications and Usage (1.2)].
  4 Due to Streptococcus pneumoniae (excluding multi-drug-resistant isolates [MDRSP]), Haemophilus influenzae, Haemophilus parainfluenzae, Mycoplasma pneumoniae, or Chlamydophila pneumoniae [see Indications and Usage (1.3)].
  5 This regimen is indicated for cUTI due to Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and AP due to E. coli, including cases with concurrent bacteremia.
  6 This regimen is indicated for cUTI due to Enterococcus faecalis, Enterococcus cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa; and for AP due to E. coli.
  7 Drug administration should begin as soon as possible after suspected or confirmed exposure to aerosolized B. anthracis. This indication is based on a surrogate endpoint. Levofloxacin plasma concentrations achieved in humans are reasonably likely to predict clinical benefit [see Clinical Studies (14.9)].
  8 The safety of levofloxacin tablets in adults for durations of therapy beyond 28 days or in pediatric patients for durations beyond 14 days has not been studied. An increased incidence of musculoskeletal adverse events compared to controls has been observed in pediatric patients [see Warnings and Precautions (5.10), Use in Specific Populations (8.4), and Clinical Studies (14.9)]. Prolonged levofloxacin tablets therapy should only be used when the benefit outweighs the risk.
  9 Drug administration should begin as soon as possible after suspected or confirmed exposure to Yersinia pestis. Higher doses of levofloxacin tablets typically used for treatment of pneumonia can be used for treatment of plague, if clinically indicated.
   Nosocomial Pneumonia
  750 mg
  7 to 14
   Community Acquired Pneumonia3
  500 mg
  7 to 14
   Community Acquired Pneumonia4
  750 mg
  5
   Acute Bacterial Sinusitis
  750 mg
  5
  500 mg
  10 to 14
   Acute Bacterial Exacerbation of Chronic Bronchitis
  500 mg
  7
   Complicated Skin and Skin Structure Infections (SSSI)
  750 mg
  7 to 14
   Uncomplicated SSSI
  500 mg
  7 to 10
   Chronic Bacterial Prostatitis
  500 mg
  28
   Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)5
  750 mg
  5
   Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)6
  250 mg
  10
   Uncomplicated Urinary Tract Infection
  250 mg
  3
   Inhalational Anthrax (Post-Exposure), adult and pediatric patients > 50 kg7,8
   Pediatric patients < 50 kg and ≥ 6 months of age 7,8
  500 mg
  
  see Table 2 below (2.2)
  608
  608
   Plague, adult and pediatric patients > 50 kg9
   Pediatric patients < 50 kg and ≥ 6 months of age
  500 mg
  see Table 2 below (2.2)
  10 to 14
  10 to 14
  2.2 Dosage in Pediatric Patients

  
  The dosage in pediatric patients ≥ 6 months of age is described below in Table 2.
  
  

  Table 2: Dosage in Pediatric Patients ≥ 6 months of age Type of Infection1 Dose Freq. Once
  every Duration2 1 Due to Bacillus anthracis [see Indications and Usage (1.13)] and Yersinia pestis [see Indications and Usage (1.14)].
  2 Sequential therapy (intravenous to oral) may be instituted at the discretion of the physician.
  3 Drug administration should begin as soon as possible after suspected or confirmed exposure to aerosolized B. anthracis. This indication is based on a surrogate endpoint. Levofloxacin plasma concentrations achieved in humans are reasonably likely to predict clinical benefit [see Clinical Studies (14.9)].
  4 The safety of levofloxacin tablets in pediatric patients for durations of therapy beyond 14 days has not been studied. An increased incidence of musculoskeletal adverse events compared to controls has been observed in pediatric patients [see Warnings and Precautions (5.10), Use in Specific Populations (8.4), and Clinical Studies (14.9)]. Prolonged levofloxacin tablets therapy should only be used when the benefit outweighs the risk.
  5 Drug administration should begin as soon as possible after suspected or confirmed exposure to Yersinia pestis.
   Inhalational Anthrax (post-exposure)3, 4
       Pediatric patients > 50 kg
  500 mg
  24 hr
  60 days4
       Pediatric patients < 50 kg and ≥ 6 months of age
  8 mg/kg
  (not to exceed
  250 mg per dose)
  12 hr
  60 days4
  Plague5
       Pediatric patients > 50 kg
  500 mg
  24 hr
  10 to 14 days
       Pediatric patients < 50 kg and ≥ 6 months of age
  8 mg/kg
  (not to exceed
  250 mg per dose)
  12 hr
  10 to 14 days
  2.3 Dosage Adjustment in Adults with Renal Impairment

  
  Administer levofloxacin tablets with caution in the presence of renal insufficiency. Careful clinical observation and appropriate laboratory studies should be performed prior to and during therapy since elimination of levofloxacin may be reduced.
  
  No adjustment is necessary for patients with a creatinine clearance ≥ 50 mL/min.
  
  In patients with impaired renal function (creatinine clearance <50 mL/min), adjustment of the dosage regimen is necessary to avoid the accumulation of levofloxacin due to decreased clearance [see Use in Specific Populations (8.6)].
  
  Table 3 shows how to adjust dose based on creatinine clearance.
  

  Table 3: Dosage Adjustment in Adult Patients with Renal Impairment (creatinine clearance <50 mL/min) Dosage in
  Normal Renal
  Function Every
  24 hours Creatinine
  Clearance
  20 to 49 mL/min Creatinine
  Clearance
  10 to 19 mL/min Hemodialysis or
  Chronic Ambulatory
  Peritoneal Dialysis
  (CAPD)    750 mg
     750 mg every 48 hours
     750 mg initial dose, then
     500 mg every 48 hours
     750 mg initial dose, then 
     500 mg every 48 hours
     500 mg
     500 mg initial dose, then 
     250 mg every 24 hours
     500 mg initial dose, then
     250 mg every 48 hours
     500 mg initial dose, then 
     250 mg every 48 hours
     250 mg
     No dosage adjustment 
     required
     250 mg every 48 hours. 
     If treating uncomplicated 
     UTI, then no dosage 
     adjustment is required
     No information on 
     dosing adjustment is available
  2.4 Drug Interaction With Chelation Agents: Antacids, Sucralfate, Metal Cations, Multivitamins
  

  Levofloxacin tablets should be administered at least two hours before or two hours after antacids containing magnesium, aluminum, as well as sucralfate, metal cations such as iron, and multivitamin preparations with zinc or didanosine chewable/buffered tablets or the pediatric powder for oral solution [see Drug Interactions (7.1) and Patient Counseling Information (17.2)].

  2.5 Administration Instructions

  
  Food and Levofloxacin Tablets
  
  Levofloxacin tablets can be administered without regard to food.
  
  Hydration for Patients Receiving Levofloxacin Tablets
  
  Adequate hydration of patients receiving oral levofloxacin tablets should be maintained to prevent the formation of highly concentrated urine. Crystalluria and cylindruria have been reported with quinolones [see Adverse Reactions (6.1)and Patient Counseling Information (17.2)].

  Close
  No Recall

  More Info
• Walgreen Company
  

  ×

  Cold And Flu | Walgreen Company

  

  ---

  • take only as directed – see Liver warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  • when using other Daytime or Nighttime products, carefully read each label to insure correct dosing

  Close
  No Recall

  More Info
• Hyvee Inc
  

  ×

  Cold And Flu | Mylan Institutional Inc.

  

  ---

  2.1 Asthma

  Montelukast sodium should be taken once daily in the evening. The following doses are recommended:

  For adults and adolescents 15 years of age and older: one 10 mg tablet.

  For pediatric patients 6 to 14 years of age: one 5 mg chewable tablet.

  For pediatric patients 2 to 5 years of age: one 4 mg chewable tablet.

  Safety and effectiveness in pediatric patients less than 12 months of age with asthma have not been established.

  There have been no clinical trials in patients with asthma to evaluate the relative efficacy of morning vs. evening dosing. The pharmacokinetics of montelukast are similar whether dosed in the morning or evening. Efficacy has been demonstrated for asthma when montelukast was administered in the evening without regard to time of food ingestion.

  2.2 Exercise-Induced Bronchoconstriction (EIB) in Patients 15 Years of Age and Older

  For prevention of EIB, a single dose of montelukast should be taken at least 2 hours before exercise. The following doses are recommended:

  For adults and adolescents 15 years of age and older: one 10 mg tablet.

  An additional dose of montelukast should not be taken within 24 hours of a previous dose. Patients already taking montelukast sodium daily for another indication (including chronic asthma) should not take an additional dose to prevent EIB. All patients should have available for rescue a short-acting β-agonist. Safety and efficacy in patients younger than 15 years of age have not been established. Daily administration of montelukast sodium for the chronic treatment of asthma has not been established to prevent acute episodes of EIB.

  Pediatric use information for patients ages 6 to 14 years of age for acute prevention of exercise-induced bronchoconstriction (EIB) is approved for Merck Sharp & Dohme Corp’s montelukast tablet products. However, due to Merck Sharp & Dohme Corp’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.

  2.3 Allergic Rhinitis

  For allergic rhinitis, montelukast sodium should be taken once daily. Efficacy was demonstrated for seasonal allergic rhinitis when montelukast was administered in the morning or the evening without regard to time of food ingestion. The time of administration may be individualized to suit patient needs.

  The following doses for the treatment of symptoms of seasonal allergic rhinitis are recommended:

  For adults and adolescents 15 years of age and older: one 10 mg tablet.

  For pediatric patients 6 to 14 years of age: one 5 mg chewable tablet.

  For pediatric patients 2 to 5 years of age: one 4 mg chewable tablet.

  Safety and effectiveness in pediatric patients younger than 2 years of age with seasonal allergic rhinitis have not been established.

  The following doses for the treatment of symptoms of perennial allergic rhinitis are recommended:

  For adults and adolescents 15 years of age and older: one 10 mg tablet.

  For pediatric patients 6 to 14 years of age: one 5 mg chewable tablet.

  For pediatric patients 2 to 5 years of age: one 4 mg chewable tablet.

  Safety and effectiveness in pediatric patients younger than 6 months of age with perennial allergic rhinitis have not been established.

  2.4 Asthma and Allergic Rhinitis

  Patients with both asthma and allergic rhinitis should take only one montelukast sodium dose daily in the evening.

  Close
  No Recall

  More Info
• Walgreen Company
  

  ×

  Cold And Flu | Ji Well Health Company

  

  ---

  Directions:

  Adults and children 12 years of age and older:

  apply to the affected area, massage for 1 minute,
  

  use not more than 3-4 times daily, wash hands.

  Children under 12 years of age: Consult a physician
  

  
  

  Close
  No Recall

  More Info
• Hyvee Inc
  

  ×

  Cold And Flu | Deseret Biologicals, Inc.

  

  ---

  1-10 drops under the tongue, 3 times a day or as directed by a health professional.  Consult a physician for use in children under 12 years of age.

  Close
  No Recall

  More Info
• Hyvee Inc
  

  ×

  Cold And Flu | Hyvee Inc

  

  ---

  • take only as directed – see Overdose warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  Close
  No Recall

  More Info
• Hyvee Inc
  

  ×

  Cold And Flu | Hyvee Inc

  

  ---

  • take only as directed - see Liver warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  • when using other Daytime or Nighttime products, carefully read each label to insure correct dosing Directions - Daytime • take only as directed - see Liver warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 4 hrs

  children 6 to under 12 yrs

  15 mL (1 TBSP) every 4 hrs

  children 4 to under 6 yrs

  ask a doctor

  children under 4 yrs

  do not use

  • when using other Daytime or Nighttime products, carefully read each label to insure correct dosing Directions - Daytime • take only as directed - see Liver warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 4 hrs

  children 6 to under 12 yrs

  15 mL (1 TBSP) every 4 hrs

  children 4 to under 6 yrs

  ask a doctor

  children under 4 yrs

  do not use

  • when using other Daytime or Nighttime products, carefully read each label to insure correct dosing

  Close
  No Recall

  More Info
• Hyvee Inc
  

  ×

  Cold And Flu | Proficient Rx Lp

  

  ---

  Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response.

  Adults

  For Edema: The usual adult dosage is 25 to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely to occur.

  For Control Of Hypertension: The usual initial dose in adults is 25 mg daily given as a single dose. The dose may be increased to 50 mg daily, given as a single or two divided doses. Doses above 50 mg are often associated with marked reductions in serum potassium (see also PRECAUTIONS).

  Patients usually do not require doses in excess of 50 mg of hydrochlorothiazide daily when used concomitantly with other antihypertensive agents.

  Infants And Children

  For Diuresis And For Control Of Hypertension: The usual pediatric dosage is 0.5 to 1 mg per pound (1 to 2 mg/kg) per day in single or two divided doses, not to exceed 37.5 mg per day in infants up to 2 years of age or 100 mg per day in children 2 to 12 years of age. In infants less than 6 months of age, doses up to 1.5 mg per pound (3 mg/kg) per day in two divided doses may be required. (See PRECAUTIONS, Pediatric Use).

  Close
  No Recall

  More Info
• Walgreen Company
  

  ×

  Cold And Flu | Walgreen Company

  

  ---

  • take only as directed – see Overdose warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  Other information • each 30 mL dose cup contains: sodium 39 mg • store at 20-25°C (68-77°F)

  Close
  No Recall

  More Info
• Hyvee Inc
  

  ×

  Cold And Flu | L&r Distributors, Inc.

  

  ---

  do not take more than directed (see overdose warning) do not take more than 4 doses per 24 hours adults and children 12 years and over: take 2 liquid caps with water every 6 hours children under 12 years: ask a doctor 

  Close
  No Recall

  More Info
• Hyvee Inc
  

  ×

  Cold And Flu | Hyvee Inc

  

  ---

  • take only as directed – see Overdose warning • use dose cup • do not exceed 4 doses per 24 hrs

  adults & children 12 yrs & over

  30 mL (2 TBSP) every 6 hrs

  children 4 to under 12 yrs

  ask a doctor

  children under 4 yrs

  do not use

  Close
  No Recall

  More Info